Sign in

CIK 0001393434

  • Large accelerated filer

OCULAR THERAPEUTIX, INC

Sign in to watch
Ticker
OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-357-4000
Business address
14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
Former names
I-THERAPEUTIX INC
  1. 4 Planned sale Dugel Pravin sold 20,880 shares at $9.02 ($188,338)
  2. 4 Exercise or conversion Director acquired 30,302 shares (option exercise)
  3. 4 Grant or award Director acquired 12,000 shares (grant or award)
  4. 4 Grant or award Director acquired 12,000 shares (grant or award)
  5. 4 Grant or award Director acquired 12,000 shares (grant or award)
  6. 4 Grant or award Director acquired 12,000 shares (grant or award)
  7. 4 Grant or award Director acquired 12,000 shares (grant or award)
  8. 4 Grant or award Chief Medical Officer acquired 141,666 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale Chief Strategy Officer sold 2,274 shares at $5.84 ($13,280)
  11. 4 Planned sale Dugel Pravin sold 21,626 shares at $5.79 ($125,215)
  12. 4 Open-market buy 10% owner bought 930,851 shares at $7.52 ($7,000,000)
  13. 4 Grant or award Executive Chairman acquired 854,979 shares (grant or award)
  14. 4 Grant or award Chief Strategy Officer acquired 80,300 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Chief Business Officer sold 5,910 shares at $4.86 ($28,723)
  18. 4 Open-market sale General Counsel sold 6,029 shares at $4.86 ($29,301)
  19. 4 Open-market sale Chief Medical Officer sold 6,346 shares at $4.86 ($30,842)
  20. 4 Open-market sale Chief Financial Officer sold 6,212 shares at $4.86 ($30,190)

Page 6 of 18 · 354 filings